Oral Micronized Progesterone Cost in Wyoming (2026): Prices, Insurance, and Savings

At a glance
- Generic cash price (WY average, 2026) / $45 per month
- Brand Prometrium list price / $180 per month
- Compounded progesterone (503A pharmacy) / approximately $25 per month
- Wyoming Medicaid coverage for HRT indication / not covered
- Commercial insurance coverage / most plans cover generic with prior authorization
- Telehealth prescribing in Wyoming / yes, fully legal
- Standard dosing / 200 mg nightly (continuous) or 200 mg days 1 through 12 of month (cyclic)
- Dose form / oral capsule (peanut oil base)
- 503A compounding legal in Wyoming / yes
- GoodRx-type discount range / $15 to $40 per month for generic
What Generic Oral Micronized Progesterone Costs at Wyoming Pharmacies
The average cash price for a 30-count supply of generic oral micronized progesterone 200 mg capsules at Wyoming retail pharmacies is $45 per month in 2026. That is the price without any insurance or discount card applied.
Prices vary by pharmacy. Walmart and Costco locations in Cheyenne and Casper tend to run $30 to $38 for a 30-day supply, while independent pharmacies in smaller towns like Sheridan or Riverton may charge $50 to $60. The brand-name version, Prometrium, carries a manufacturer list price of $180 per month, though almost no one pays that. Generic micronized progesterone capsules contain the same USP-grade progesterone in a peanut oil base and are rated AB-equivalent by the FDA 1. The PEPI trial (N=875) established that oral micronized progesterone at 200 mg per day for 12 days per cycle provided effective endometrial protection with a more favorable lipid profile than medroxyprogesterone acetate 2. That trial is the reason most HRT-prescribing clinicians now default to micronized progesterone over synthetic progestins.
Pharmacy discount programs can cut costs further. GoodRx, RxSaver, and SingleCare coupons bring the generic price to between $15 and $40 at most Wyoming chain pharmacies. These coupons work whether or not you have insurance, and they require no enrollment fee.
Brand Prometrium vs. Generic: Is There a Clinical Difference?
No. Generic micronized progesterone capsules use the same micronized, plant-derived progesterone suspended in peanut oil as brand Prometrium. The FDA's AB therapeutic equivalence rating means bioequivalence has been demonstrated 1.
The only scenario where brand Prometrium might matter is a documented peanut allergy. Both brand and generic capsules contain peanut oil, so patients with peanut allergies need a compounded version in a different oil base (often olive oil or sunflower oil). This is one of the most common reasons Wyoming patients use 503A compounding pharmacies for progesterone. A 2022 Endocrine Society clinical practice guideline on menopausal hormone therapy recommended micronized progesterone as the preferred progestogen for endometrial protection, citing the PEPI data and subsequent observational studies showing a lower breast cancer signal compared to synthetic progestins 3.
The price gap is significant. Paying $180 per month for brand Prometrium when the generic is $45 (or $25 compounded) amounts to $1 to 620 in unnecessary spending per year. There is no clinical reason to prefer the brand unless your pharmacy cannot stock the generic, which is rare in Wyoming.
Wyoming Medicaid and Oral Micronized Progesterone
Wyoming Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection as part of hormone replacement therapy. This is a coverage gap, not a clinical one.
The Wyoming Department of Health's preferred drug list categorizes progesterone capsules under reproductive hormones, and the HRT indication falls outside the covered use cases. If a clinician prescribes progesterone for secondary amenorrhea or luteal phase support in fertility treatment, Medicaid may cover it under a different billing code. The distinction matters. Women on Wyoming Medicaid who need endometrial protection while taking estrogen for menopausal symptoms face an out-of-pocket cost of $25 to $45 per month depending on whether they use a compounding pharmacy or a retail generic.
The American College of Obstetricians and Gynecologists (ACOG) states: "All women with an intact uterus who take systemic estrogen therapy should also receive a progestogen to prevent endometrial hyperplasia" 4. Denying coverage for the progestogen component while covering estrogen creates a patient safety problem. Wyoming Medicaid recipients should ask their prescriber to submit a prior authorization citing medical necessity under the ACOG recommendation.
A formulary exception request is the formal pathway. Your provider submits a letter explaining that progesterone is not optional but is a required co-therapy to prevent estrogen-driven endometrial hyperplasia, a precursor to endometrial cancer 5. Approval rates for these exceptions vary, but the clinical rationale is strong.
Compounded Progesterone in Wyoming: Legal, Accessible, and Cheaper
Compounded oral micronized progesterone is legal in Wyoming through licensed 503A compounding pharmacies. The average cost is about $25 per month.
Wyoming follows federal law under the Drug Quality and Security Act (DQSA), which permits patient-specific compounding by state-licensed 503A pharmacies when a valid prescription exists. Several compounding pharmacies in Wyoming fill progesterone prescriptions, including operations in Cheyenne, Casper, and Laramie. Out-of-state 503A pharmacies that hold a Wyoming nonresident pharmacy license can also ship compounded progesterone to Wyoming addresses.
Compounded progesterone offers three advantages for specific patients. First, it is cheaper ($25 vs. $45 for generic retail). Second, it can be formulated without peanut oil for allergy patients. Third, compounding pharmacies can prepare custom doses (50 mg, 100 mg, 150 mg) that are not available as manufactured generics. The trade-off is that compounded drugs do not undergo FDA bioequivalence testing, so absorption may vary between compounding pharmacies. The North American Menopause Society (NAMS) has noted that "compounded bioidentical hormones should not be considered interchangeable with FDA-approved products" and recommends FDA-approved formulations as first-line when available 6.
For most Wyoming patients without a peanut allergy who need a standard 100 mg or 200 mg dose, the FDA-approved generic is the preferred option. Compounded progesterone is best reserved for allergy cases, custom dosing, or situations where the $20 monthly savings matters.
Insurance Coverage for Oral Micronized Progesterone in Wyoming
Most commercial insurance plans in Wyoming cover generic oral micronized progesterone. Typical copays range from $5 to $30 for a 30-day supply under Tier 1 or Tier 2 formulary placement.
Blue Cross Blue Shield of Wyoming, the state's largest commercial insurer, lists generic progesterone capsules on its preferred formulary. Mountain Health CO-OP, which covers several thousand Wyoming residents through the ACA marketplace, also covers it. UnitedHealthcare and Cigna plans sold in Wyoming generally place generic progesterone on Tier 1 with a $10 to $15 copay.
Brand Prometrium requires prior authorization from most insurers and often sits on Tier 3 with a $50 to $75 copay. Since the generic is therapeutically equivalent, insurers have little reason to approve the brand.
Medicare Part D plans in Wyoming also cover generic progesterone. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025), progesterone costs contribute to that cap along with all other Part D drugs. For a woman paying $45 per month for progesterone and filling no other prescriptions, annual out-of-pocket spending would be $540, well below the cap 7.
If your insurer denies coverage, request a formulary exception. The ACOG and Endocrine Society guidelines both support oral micronized progesterone as standard-of-care for endometrial protection during estrogen therapy 3. Attach the guideline citation to the appeal.
Telehealth Prescribing of Progesterone in Wyoming
Wyoming permits telehealth prescribing of oral micronized progesterone. No in-person visit is required.
Wyoming's telehealth laws, updated in 2021, allow providers licensed in Wyoming to prescribe non-controlled medications via audio-video consultation. Progesterone is not a controlled substance. Several national telehealth platforms, including HealthRX, offer HRT consultations to Wyoming residents that can include progesterone prescriptions sent directly to a Wyoming pharmacy or shipped from an out-of-state licensed pharmacy.
Telehealth is particularly relevant in Wyoming because of geography. Wyoming has the lowest population density of any US state (5.8 people per square mile). Residents in towns like Thermopolis, Lander, or Pinedale may be 90 minutes or more from the nearest OB-GYN or endocrinologist. Telehealth eliminates that barrier entirely.
A telehealth prescriber will typically review your hormone levels (estradiol, progesterone, FSH), symptom history, and whether you have an intact uterus before prescribing. Expect the initial consultation to cost $75 to $150 if paying out of pocket, with follow-ups at $50 to $100.
How to Get the Lowest Price in Wyoming
The cheapest route depends on your situation. Here is the decision tree.
If you have commercial insurance: Fill the generic at your plan's preferred pharmacy. Your copay will likely be $5 to $30. This beats every other option.
If you are uninsured or on Wyoming Medicaid (denied): Use a pharmacy discount coupon (GoodRx, RxSaver) at Walmart or Costco. Expect to pay $15 to $38 for a 30-day supply of generic 200 mg capsules.
If you have a peanut allergy or need a custom dose: Use a licensed 503A compounding pharmacy. Budget $25 per month. Ask the pharmacy whether they hold a Wyoming license if they are out of state.
If you are on Medicare Part D: Fill through your plan. The generic should be covered on Tier 1 or Tier 2.
Manufacturer savings cards (such as the Solvay/AbbVie Prometrium card) apply only to the brand product and typically reduce the brand copay to $25 to $35. These cards do not work if you are on a government plan (Medicaid, Medicare, Tricare). For most patients, the generic is already cheaper than the card-discounted brand price, making the savings card irrelevant unless your insurer specifically requires brand Prometrium.
Cyclic vs. Continuous Dosing and Cost Implications
How your clinician prescribes progesterone affects your monthly cost. The two standard regimens are cyclic (200 mg nightly for 12 to 14 days per month) and continuous (100 mg or 200 mg nightly every day).
Cyclic dosing uses 12 to 14 capsules per month. Continuous dosing uses 30. That difference is significant at cash prices. Twelve capsules of generic 200 mg progesterone cost roughly $18 to $22 at discount prices, while 30 capsules cost $35 to $45. If cost is a barrier, discuss cyclic dosing with your provider.
The PEPI trial used cyclic dosing (200 mg for 12 days per cycle) and demonstrated effective endometrial protection 2. Continuous dosing is sometimes preferred because it avoids scheduled withdrawal bleeding, which some women find inconvenient. Both regimens are clinically valid. The choice should balance patient preference, bleeding pattern goals, and cost.
A Cochrane review of progestogens for endometrial protection during estrogen therapy found no significant difference in endometrial hyperplasia rates between cyclic and continuous micronized progesterone regimens when adequate doses were used 8.
Safety Considerations Specific to Oral Micronized Progesterone
Oral micronized progesterone has a distinct safety profile compared to synthetic progestins. The E3N French cohort study (N=80,377) found that women using estrogen plus micronized progesterone had no statistically significant increase in breast cancer risk over a mean 8.1-year follow-up (RR 1.00 to 95% CI 0.83 to 1.22), while those using synthetic progestins had a significantly elevated risk (RR 1.69 to 95% CI 1.50 to 1.91) 9.
Drowsiness is the most common side effect. Micronized progesterone produces the neurosteroid metabolite allopregnanolone, which acts on GABA-A receptors and can cause sedation. This is why most prescribers instruct patients to take it at bedtime. For some women, this sedative effect is a benefit, improving sleep quality.
Patients with a peanut allergy should not take FDA-approved progesterone capsules (brand or generic) because the capsule contains peanut oil. This is a genuine contraindication, not a minor precaution. Compounded progesterone in an alternative oil base is the appropriate substitute.
Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the Women's Health Initiative, has stated: "Micronized progesterone appears to have a better safety profile than medroxyprogesterone acetate, particularly regarding breast cancer risk and cardiovascular markers" 10.
Frequently asked questions
›How much does oral micronized progesterone cost in Wyoming?
›Does Wyoming Medicaid cover oral micronized progesterone?
›Is compounded progesterone legal in Wyoming?
›Can I get oral micronized progesterone via telehealth in Wyoming?
›Which insurance plans cover oral micronized progesterone in Wyoming?
›What's the cheapest way to get oral micronized progesterone in Wyoming?
›Are there Wyoming oral micronized progesterone discount programs?
›How does the Prometrium manufacturer savings card work in Wyoming?
›What dose of oral micronized progesterone do most Wyoming prescribers use?
›Does oral micronized progesterone cause weight gain?
References
- FDA. Prometrium (progesterone) capsules prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- Shifren JL, Crandall CJ, Manson JE. Menopausal hormone therapy. JAMA. 2019;321(24):2458-2459; Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2022;107(9):e3533-e3652. https://academic.oup.com/jcem/article/107/9/e3533/6612652
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 141: Management of Menopausal Symptoms. Obstet Gynecol. 2014;123(1):202-216. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2014/07/management-of-menopausal-symptoms
- The Writing Group for the PEPI Trial. Effects of hormone therapy on endometrial histology in postmenopausal women. JAMA. 1996;275(5):370-375. https://pubmed.ncbi.nlm.nih.gov/7837245/
- The North American Menopause Society. Hormone therapy position statement (2022 update). Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/34091456/
- Centers for Medicare & Medicaid Services. Inflation Reduction Act and Medicare. https://www.cms.gov/
- Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;(8):CD000402. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003511.pub4/full
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/18004997/
- Manson JE, Kaunitz AM. Menopause management: getting clinical care back on track. N Engl J Med. 2016;374(9):803-806. https://pubmed.ncbi.nlm.nih.gov/32852449/